# Prevalence of Significant Liver Fibrosis and Inflammation in Chronic HBV Infected Patients in Grey Zone

> **NCT05483049** · — · UNKNOWN · sponsor: **Ruijin Hospital** · enrollment: 600 (estimated)

## Conditions studied

- Chronic Hepatitis b

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05483049
- **Lead sponsor:** Ruijin Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-09-01
- **Primary completion:** 2023-03-31
- **Final completion:** 2023-08-31
- **Target enrollment:** 600 (ESTIMATED)
- **Last updated:** 2022-08-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05483049

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05483049, "Prevalence of Significant Liver Fibrosis and Inflammation in Chronic HBV Infected Patients in Grey Zone". Retrieved via AI Analytics 2026-06-22 from https://api.ai-analytics.org/clinical/NCT05483049. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*